Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can) — Stella

Recruiting

Back to Subdural Hematoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

Health Sciences centre, Winnipeg MB, Manitoba

Key details

Sponsor

University of Manitoba

Enrollment target

~1,000 participants

Started

May 2021

Primary completion

December 2029

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov